Comments
Drug for rare disease may lift AVI BioPharma shares: Barron's
02.04.2012. | NEW YORK (Reuters) - AVI BioPharma Inc's shares could get a boost if its drug targeting treatment for a rare fatal form of muscular dystrophy proves to be effective in clinical drug trials, according to an article in the April 2 edition of Barron's....
